We are live on ! Find out more
CVS icon

CVS Health

1,211 hedge funds and large institutions have $71.4B invested in CVS Health in 2013 Q4 according to their latest regulatory filings, with 157 funds opening new positions, 425 increasing their positions, 492 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 157 | Existing positions closed: 65

65% more funds holding in top 10

Funds holding in top 10: 83137 (+54)

22% more capital invested

Capital invested by funds: $58.3B → $71.4B (+$13.1B)

7% more funds holding

Funds holding: 1,1301,211 (+81)

9% more call options, than puts

Call options by funds: $355M | Put options by funds: $326M

0.98% more ownership

Funds ownership: 82.97%83.95% (+0.98%)

14% less repeat investments, than reductions

Existing positions increased: 425 | Existing positions reduced: 492

Holders
1,211
Holders Change
+81
Holders Change %
+7.17%
% of All Funds
35.14%
Holding in Top 10
137
Holding in Top 10 Change
+54
Holding in Top 10 Change %
+65.06%
% of All Funds
3.98%
New
157
Increased
425
Reduced
492
Closed
65
Calls
$355M
Puts
$326M
Net Calls
+$29.3M
Net Calls Change
+$78.1M
Name Holding Trade Value Shares
Change
Change in
Stake
VCM
426
Violich Capital Management
California
$8.1M +$114K +1,769 +2%
HighTower Advisors
427
HighTower Advisors
Illinois
$8.1M +$2.31M +36,013 +47%
VAM
428
Visium Asset Management
New York
$8.04M -$1.42M -22,079 -16%
TFA
429
Toth Financial Advisory
Virginia
$7.98M +$182K +2,832 +3%
FMII
430
Farmers & Merchants Investments Inc
Nebraska
$7.88M +$87.9K +1,368 +1%
NB
431
NBT Bank
New York
$7.84M -$449K -6,983 -6%
Connor, Clark & Lunn Investment Management (CC&L)
432
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$7.78M +$3.43M +53,325 +109%
CAM
433
Carret Asset Management
New York
$7.71M +$33.3K +519 +0.5%
SAM
434
Securian Asset Management
Minnesota
$7.68M -$236K -3,666 -3%
ABC
435
Associated Banc-Corp
Wisconsin
$7.68M +$1.14M +17,790 +20%
RPAM
436
Rhenman & Partners Asset Management
Sweden
$7.66M +$6.87M +107,000 New
OWD
437
Osborn Williams & Donohoe
Ohio
$7.66M +$151K +2,349 +2%
WB
438
Webster Bank
Connecticut
$7.63M -$355K -5,525 -5%
MAM
439
Martingale Asset Management
Massachusetts
$7.62M -$15.3M -237,576 -69%
NCM
440
Novare Capital Management
North Carolina
$7.61M +$141K +2,200 +2%
NEAM
441
New England Asset Management
Connecticut
$7.58M -$45K -700 -0.7%
Janney Montgomery Scott
442
Janney Montgomery Scott
Pennsylvania
$7.42M +$170K +2,639 +3%
CANC
443
Culbertson A N & Co
Virginia
$7.38M +$28.9K +450 +0.4%
AMI
444
Amica Mutual Insurance
Rhode Island
$7.36M
LAM
445
Lingohr Asset Management
Germany
$7.25M -$2.24M -34,866 -26%
BPM
446
Bowling Portfolio Management
Ohio
$7.07M -$47.4K -737 -0.7%
AAM
447
Auxier Asset Management
Oregon
$7.05M -$3.21K -50 -0.1%
AI
448
Ariel Investments
Illinois
$7.04M +$2.75M +42,735 +77%
MPM
449
Meritage Portfolio Management
Kansas
$7.03M -$326K -5,073 -5%
KRS
450
Kentucky Retirement Systems
Kentucky
$7.03M -$242K -3,762 -4%

CVS Hedge Fund Activity: Q4 2013 in Review

1,211 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2013, worth a combined $71.4B — up 22% from $58.3B a quarter earlier.

Buyers outnumbered sellers: 157 funds opened new CVS positions and 65 closed out — a net gain of 92 holders — while 425 added to existing stakes and 492 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $207M. The largest seller was Fidelity Investments, cutting an estimated $557M.

  • 1,211 institutional investors held CVS Health (CVS) as of Q4 2013, up from 1,130 in Q3 2013.
  • Funds reported $71.4B of CVS Health stock for Q4 2013, up 22% quarter-over-quarter.
  • 157 funds opened new CVS Health positions in Q4 2013 and 65 closed out, a net change of +92 holders.
  • The largest CVS Health buyer in Q4 2013 was AllianceBernstein, an estimated $207M added.
  • The largest CVS Health seller in Q4 2013 was Fidelity Investments, an estimated $557M sold.

Based on aggregated 13F filings for Q4 2013.